共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R020384-25mg | 25mg | 5~7个工作日 |
陶扎色替 Tozaserti |
98% |
|
|
罗恩 | R020384-100mg | 100mg | 5~7个工作日 |
陶扎色替 Tozaserti |
98% |
|
|
阿拉丁 | T127762-25mg | 25mg | 现货 |
陶扎色替 Tozaserti |
Moligand™, ≥98% |
|
|
阿拉丁 | T127762-100mg | 100mg | 现货 |
陶扎色替 Tozaserti |
Moligand™, ≥98% |
|
|
阿拉丁 | T407973-1ml | 1ml | 现货 |
Tozasertib (VX-680, MK-0457) Tozasertib (VX-680, MK-0457) |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ003840-5mg | 5mg | 期货,请咨询 |
N-[4-[[4-(4-甲基-1-哌嗪基)-6-[(5-... N-[4-[[4-(4-Methyl-1-piperaz... |
99+% |
|
|
凯为 | JZ003840-10mg | 10mg | 期货,请咨询 |
N-[4-[[4-(4-甲基-1-哌嗪基)-6-[(5-... N-[4-[[4-(4-Methyl-1-piperaz... |
99+% |
|
|
凯为 | JZ003840-25mg | 25mg | 期货,请咨询 |
N-[4-[[4-(4-甲基-1-哌嗪基)-6-[(5-... N-[4-[[4-(4-Methyl-1-piperaz... |
99+% |
|
|
凯为 | JZ003840-50mg | 50mg | 期货,请咨询 |
N-[4-[[4-(4-甲基-1-哌嗪基)-6-[(5-... N-[4-[[4-(4-Methyl-1-piperaz... |
99+% |
|
|
凯为 | JZ003840-100mg | 100mg | 期货,请咨询 |
N-[4-[[4-(4-甲基-1-哌嗪基)-6-[(5-... N-[4-[[4-(4-Methyl-1-piperaz... |
99+% |
|
|
凯为 | JZ003840-250mg | 250mg | 期货,请咨询 |
N-[4-[[4-(4-甲基-1-哌嗪基)-6-[(5-... N-[4-[[4-(4-Methyl-1-piperaz... |
99+% |
|
|
凯为 | JZ003840-1g | 1g | 期货,请咨询 |
N-[4-[[4-(4-甲基-1-哌嗪基)-6-[(5-... N-[4-[[4-(4-Methyl-1-piperaz... |
99+% |
|
|
毕得 | BD161453-25mg | 25mg | 现货 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-50mg | 50mg | 现货 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-100mg | 100mg | 现货 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-250mg | 250mg | 现货 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-10mg | 10mg | 现货 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-5mg | 5mg | 现货 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
毕得 | BD161453-1g | 1g | 现货 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
|
|
TRC | T700000-25mg | 25mg | 期货,请咨询 |
陶扎色替 Tozaserti -20度保存 |
>95% |
|
|
Matrix | MA143761-1g | 1g | 3-4周 |
N-(4-(4-(5-Methyl-1H-pyrazol... N-(4-(4-(5-Methyl-1H-pyrazol... |
95% | 咨询 | 请联系客服购买! |
Matrix | MA143761-5g | 5g | 3-4周 |
N-(4-(4-(5-Methyl-1H-pyrazol... N-(4-(4-(5-Methyl-1H-pyrazol... |
95% | 咨询 | 请联系客服购买! |
源叶 | S49418-25mg | 25mg | 现货 |
Tozasertib Tozaserti |
≥98% |
|
|
源叶 | S49418-100mg | 100mg | 现货 |
Tozasertib Tozaserti |
≥98% |
|
|
源叶 | T98824-1ml | 1ml | 期货,请咨询 |
Tozasertib (VX-680, MK-0457) Tozasertib (VX-680, MK-0457) |
10mM in DMSO |
|
|
Target Mol | T2509-25mg | 25mg | 现货 |
化合物 Tozasertib Tozaserti |
99.99% |
|
|
Target Mol | T2509-50mg | 50mg | 现货 |
化合物 Tozasertib Tozaserti |
99.99% |
|
|
Target Mol | T2509-100mg | 100mg | 现货 |
化合物 Tozasertib Tozaserti |
99.99% |
|
|
Target Mol | T2509-200mg | 200mg | 现货 |
化合物 Tozasertib Tozaserti |
99.99% |
|
|
Target Mol | T2509-1mL | 1mL | 现货 |
化合物 Tozasertib Tozaserti |
99.99% |
|
|
Target Mol | T2509-10mg | 10mg | 现货 |
化合物 Tozasertib Tozaserti |
99.99% |
|
|
Am | A153482-250mg | 250mg | 现货 |
Tozasertib Tozaserti |
99+% |
|
|
Am | A153482-5mg | 5mg | 现货 |
Tozasertib Tozaserti |
99+% |
|
|
Am | A153482-10mg | 10mg | 现货 |
Tozasertib Tozaserti |
99+% |
|
|
Am | A153482-1mg | 1mg | 现货 |
Tozasertib Tozaserti |
99+% |
|
|
Am | A153482-100mg | 100mg | 现货 |
Tozasertib Tozaserti |
99+% |
|
|
Am | A153482-25mg | 25mg | 现货 |
Tozasertib Tozaserti |
99+% |
|
|
Am | A153482-50mg | 50mg | 现货 |
Tozasertib Tozaserti |
99+% |
|
|
MCE | HY-10161-100mg | 100mg | 现货 |
Tozasertib Tozaserti |
99.94% |
|
|
MCE | HY-10161-50mg | 50mg | 现货 |
Tozasertib Tozaserti |
99.94% |
|
|
MCE | HY-10161-10mM*1mL | 10mM*1mL | 现货 |
Tozasertib Tozaserti |
99.94% |
|
|
MCE | HY-10161-25mg | 25mg | 现货 |
Tozasertib Tozaserti |
99.94% |
|
|
MCE | HY-10161-10mg | 10mg | 现货 |
Tozasertib Tozaserti |
99.94% |
|
|
MCE | HY-10161-5mg | 5mg | 现货 |
Tozasertib Tozaserti |
99.94% |
|
|